TY - JOUR
T1 - Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability
AU - Li, Lin
AU - Ghorbani, Mohammad
AU - Weisz-Hubshman, Monika
AU - Rousseau, Justine
AU - Thiffault, Isabelle
AU - Schnur, Rhonda E.
AU - Breen, Catherine
AU - Oegema, Renske
AU - Weiss, Marjan M.M.
AU - Waisfisz, Quinten
AU - Welner, Sara
AU - Kingston, Helen
AU - Hills, Jordan A.
AU - Boon, Elles M.J.
AU - Basel-Salmon, Lina
AU - Konen, Osnat
AU - Goldberg-Stern, Hadassa
AU - Bazak, Lily
AU - Tzur, Shay
AU - Jin, Jianliang
AU - Bi, Xiuli
AU - Bruccoleri, Michael
AU - McWalter, Kirsty
AU - Cho, Megan T.
AU - Scarano, Maria
AU - Schaefer, G. Bradley
AU - Brooks, Susan S.
AU - Hughes, Susan Starling
AU - Van Gassen, K. L.I.
AU - Van Hagen, Johanna M.
AU - Pandita, Tej K.
AU - Agrawal, Pankaj B.
AU - Campeau, Philippe M.
AU - Yang, Xiang Jiao
N1 - Publisher Copyright:
© 2020, American Society for Clinical Investigation.
PY - 2020/3/2
Y1 - 2020/3/2
N2 - Epigenetic integrity is critical for many eukaryotic cellular processes. An important question is how different epigenetic regulators control development and influence disease. Lysine acetyltransferase 8 (KAT8) is critical for acetylation of histone H4 at lysine 16 (H4K16), an evolutionarily conserved epigenetic mark. It is unclear what roles KAT8 plays in cerebral development and human disease. Here, we report that cerebrum-specific knockout mice displayed cerebral hypoplasia in the neocortex and hippocampus, along with improper neural stem and progenitor cell (NSPC) development. Mutant cerebrocortical neuroepithelia exhibited faulty proliferation, aberrant neurogenesis, massive apoptosis, and scant H4K16 propionylation. Mutant NSPCs formed poor neurospheres, and pharmacological KAT8 inhibition abolished neurosphere formation. Moreover, we describe KAT8 variants in 9 patients with intellectual disability, seizures, autism, dysmorphisms, and other anomalies. The variants altered chromobarrel and catalytic domains of KAT8, thereby impairing nucleosomal H4K16 acetylation. Valproate was effective for treating epilepsy in at least 2 of the individuals. This study uncovers a critical role of KAT8 in cerebral and NSPC development, identifies 9 individuals with KAT8 variants, and links deficient H4K16 acylation directly to intellectual disability, epilepsy, and other developmental anomalies.
AB - Epigenetic integrity is critical for many eukaryotic cellular processes. An important question is how different epigenetic regulators control development and influence disease. Lysine acetyltransferase 8 (KAT8) is critical for acetylation of histone H4 at lysine 16 (H4K16), an evolutionarily conserved epigenetic mark. It is unclear what roles KAT8 plays in cerebral development and human disease. Here, we report that cerebrum-specific knockout mice displayed cerebral hypoplasia in the neocortex and hippocampus, along with improper neural stem and progenitor cell (NSPC) development. Mutant cerebrocortical neuroepithelia exhibited faulty proliferation, aberrant neurogenesis, massive apoptosis, and scant H4K16 propionylation. Mutant NSPCs formed poor neurospheres, and pharmacological KAT8 inhibition abolished neurosphere formation. Moreover, we describe KAT8 variants in 9 patients with intellectual disability, seizures, autism, dysmorphisms, and other anomalies. The variants altered chromobarrel and catalytic domains of KAT8, thereby impairing nucleosomal H4K16 acetylation. Valproate was effective for treating epilepsy in at least 2 of the individuals. This study uncovers a critical role of KAT8 in cerebral and NSPC development, identifies 9 individuals with KAT8 variants, and links deficient H4K16 acylation directly to intellectual disability, epilepsy, and other developmental anomalies.
UR - http://www.scopus.com/inward/record.url?scp=85081140075&partnerID=8YFLogxK
U2 - 10.1172/JCI131145
DO - 10.1172/JCI131145
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31794431
AN - SCOPUS:85081140075
SN - 0021-9738
VL - 130
SP - 1431
EP - 1445
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -